These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 30129266)

  • 1. Hyponatremia in Cirrhosis: Implications for Liver Transplantation.
    Leise M; Cárdenas A
    Liver Transpl; 2018 Nov; 24(11):1612-1621. PubMed ID: 30129266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sodium homeostasis during liver transplantation and correlation with outcomes.
    Hudcova J; Ruthazer R; Bonney I; Schumann R
    Anesth Analg; 2014 Dec; 119(6):1420-8. PubMed ID: 25211389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hyponatremia in Liver Cirrhosis].
    Jang CM; Jung YK
    Korean J Gastroenterol; 2018 Aug; 72(2):74-78. PubMed ID: 30145859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of preoperative sodium concentration on outcome of patients with hepatitis B virus cirrhosis after liver transplantation.
    Wang P; Huang G; Tam N; Wu C; Fu S; Hughes BP; Wu L; He X
    Eur J Gastroenterol Hepatol; 2016 Oct; 28(10):1210-5. PubMed ID: 27362549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between the Serum Sodium Levels and the Response to Tolvaptan in Liver Cirrhosis Patients with Ascites and Hyponatremia.
    Hayashi M; Abe K; Fujita M; Okai K; Takahashi A; Ohira H
    Intern Med; 2018 Sep; 57(17):2451-2458. PubMed ID: 29607963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Approach and management of dysnatremias in cirrhosis.
    Bernardi M; Zaccherini G
    Hepatol Int; 2018 Nov; 12(6):487-499. PubMed ID: 30203382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ten pitfalls in the proper management of patients with hyponatremia.
    Filippatos TD; Liamis G; Elisaf MS
    Postgrad Med; 2016 Jun; 128(5):516-22. PubMed ID: 27153450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for central pontine and extrapontine myelinolysis after liver transplantation: a single-center study.
    Crivellin C; Cagnin A; Manara R; Boccagni P; Cillo U; Feltracco P; Barbieri S; Ferrarese A; Germani G; Russo FP; Burra P; Senzolo M
    Transplantation; 2015 Jun; 99(6):1257-64. PubMed ID: 25427166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central Pontine Myelinolysis After Living-Donor Liver Transplant: A Report of 2 Cases.
    Hsu YL; Hsieh CE; Lin KH; Chou CT; Lin PY; Wang SH; Chen YL
    Exp Clin Transplant; 2019 Aug; 17(4):564-567. PubMed ID: 29137593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limited Efficacy of Tolvaptan in Patients with Cirrhosis and Severe Hyponatremia: Real-Life Experience.
    Pose E; Solà E; Piano S; Gola E; Graupera I; Guevara M; Cárdenas A; Angeli P; Ginès P
    Am J Med; 2017 Mar; 130(3):372-375. PubMed ID: 27746291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death.
    Heuman DM; Abou-Assi SG; Habib A; Williams LM; Stravitz RT; Sanyal AJ; Fisher RA; Mihas AA
    Hepatology; 2004 Oct; 40(4):802-10. PubMed ID: 15382176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osmotic Demyelination Unrelated to Hyponatremia.
    Shah MK; Mandayam S; Adrogué HJ
    Am J Kidney Dis; 2018 Mar; 71(3):436-440. PubMed ID: 29277507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyponatremia in cirrhosis: pathophysiology and management.
    John S; Thuluvath PJ
    World J Gastroenterol; 2015 Mar; 21(11):3197-205. PubMed ID: 25805925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypervolemic Hyponatremia (Liver).
    Solà E; Ginès P
    Front Horm Res; 2019; 52():104-112. PubMed ID: 32097916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Changing Role of Sodium Management in Cirrhosis.
    Lizaola B; Bonder A; Tapper EB; Mendez-Bocanegra A; Cardenas A
    Curr Treat Options Gastroenterol; 2016 Jun; 14(2):274-84. PubMed ID: 27037930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sodium-reduced continuous venovenous hemodiafiltration (CVVHDF) for the prevention of central pontine myelinolysis (CPM) in hyponatremic patients scheduled for orthotopic liver transplantation.
    Lenk MR; Kaspar M
    J Clin Anesth; 2012 Aug; 24(5):407-11. PubMed ID: 22658371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Implications, Evaluation, and Management of Hyponatremia in Cirrhosis.
    Praharaj DL; Anand AC
    J Clin Exp Hepatol; 2022; 12(2):575-594. PubMed ID: 35535075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occult central pontine myelinolysis post liver transplant: A consequence of pre-transplant hyponatremia.
    Zhu J; Al-Alkim F; Hussaini T; Vertinsky A; Byrne D; Erb SR; Stoessl AJ; Yoshida EM
    Ann Hepatol; 2019; 18(4):651-654. PubMed ID: 31056363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of Tolvaptan in the Perioperative Management of Severe Hyponatremia During Liver Transplantation: A Case Report.
    Parekh A; Rajaram P; Patel G; Subramanian RM
    Transplant Proc; 2017 Dec; 49(10):2399-2401. PubMed ID: 29198689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the pretransplant serum sodium concentration on outcomes following liver transplantation.
    Leise MD; Yun BC; Larson JJ; Benson JT; Yang JD; Therneau TM; Rosen CB; Heimbach JK; Biggins SW; Kim WR
    Liver Transpl; 2014 Jun; 20(6):687-97. PubMed ID: 24616214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.